JPS61263917A - 脳機能正常化剤 - Google Patents

脳機能正常化剤

Info

Publication number: JPS61263917A
Authority: JP; Japan
Prior art keywords: cerebral; agent; normalizing; pyrazolin; formula
Prior art date: 1985-05-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

JP10579885A

Other languages

English (en)

Japanese (ja)

Other versions

JPH0531523B2 (2

Inventor

Hiroyoshi Nishi

西　廣吉

Toshiaki Watanabe

俊明渡辺

Toshiyuki Yuki

敏志幸

Yasuhiro Morinaka

盛中　泰洋

Katsuhiko Izeki

克彦伊関

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Mitsubishi Yuka Pharmaceutical Co Ltd

Original Assignee

Mitsubishi Yuka Pharmaceutical Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-05-20

Filing date

1985-05-20

Publication date

1986-11-21

1985-05-20 Application filed by Mitsubishi Yuka Pharmaceutical Co Ltd filed Critical Mitsubishi Yuka Pharmaceutical Co Ltd

1985-05-20 Priority to JP10579885A priority Critical patent/JPS61263917A/ja

1986-05-16 Priority to DK227186A priority patent/DK169672B1/da

1986-05-20 Priority to EP86106817A priority patent/EP0208874B1/en

1986-05-20 Priority to DE8686106817T priority patent/DE3673273T2/de

1986-11-21 Publication of JPS61263917A publication Critical patent/JPS61263917A/ja

1987-11-19 Priority to US07/122,516 priority patent/US4857542A/en

1993-05-12 Publication of JPH0531523B2 publication Critical patent/JPH0531523B2/ja

1994-09-20 Priority to US08/309,558 priority patent/USRE35801E/en

Status Granted legal-status Critical Current

Links

Landscapes

Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

JP10579885A 1985-05-20 1985-05-20 脳機能正常化剤 Granted JPS61263917A (ja)

Priority Applications (6)

Application Number	Priority Date	Filing Date	Title
JP10579885A JPS61263917A (ja)	1985-05-20	1985-05-20	脳機能正常化剤
DK227186A DK169672B1 (da)	1985-05-20	1986-05-16	Farmaceutiske præparater indeholdende pyrazolonderivater som aktiv bestanddel og anvendelsen af pyrazolonderivater til fremstilling af farmaceutiske præparater
EP86106817A EP0208874B1 (en)	1985-05-20	1986-05-20	Prophylactic and therapeutic agent for circulatory disorders
DE8686106817T DE3673273T2 (de)	1985-05-20	1986-05-20	Prophylaktische und therapeutische mittel fuer kreislaufkrankheiten.
US07/122,516 US4857542A (en)	1985-05-20	1987-11-19	Prophylactic and therapeutic composition for circulatory disorders and method of treatment
US08/309,558 USRE35801E (en)	1985-05-20	1994-09-20	Prophylactic and therapeutic composition for circulatory disorders and method of treatment

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP10579885A JPS61263917A (ja)	1985-05-20	1985-05-20	脳機能正常化剤

Publications (2)

Publication Number	Publication Date
JPS61263917A true JPS61263917A (ja)	1986-11-21
JPH0531523B2 JPH0531523B2 (2)	1993-05-12

Family

ID=14417138

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP10579885A Granted JPS61263917A (ja)	1985-05-20	1985-05-20	脳機能正常化剤

Country Status (1)

Country	Link
JP (1)	JPS61263917A (2)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01242526A (ja) *	1988-03-23	1989-09-27	Takeda Chem Ind Ltd	カルバメート化合物
JPWO2005054205A1 (ja) *	2003-12-05	2007-06-28	学校法人東海大学	蛋白修飾物生成抑制剤
US8076368B2 (en)	2003-11-12	2011-12-13	Lead Chemical Co., Ltd,	Percutaneous absorption type cerebral protective agent

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2414586C (en)	2000-06-29	2009-09-29	Mitsubishi Pharma Corporation	Agent for therapeutic treatment of optic nerve diseases and the like
JP2004346067A (ja) *	2003-04-28	2004-12-09	Mitsubishi Pharma Corp	抗血栓薬の治療可能時間を延長するための薬剤
KR101255578B1 (ko)	2004-08-10	2013-04-17	미쓰비시 타나베 파마 코퍼레이션	뇌경색에 연관된 뇌혈관 장애를 치료하는데 유용한피라졸론 화합물
JPWO2006126625A1 (ja) *	2005-05-25	2008-12-25	田辺三菱製薬株式会社	ピラゾロン誘導体を含む医薬
JP2008001605A (ja) *	2006-06-20	2008-01-10	Mitsubishi Pharma Corp	ピラゾロン化合物を含有する水溶液剤
CN101917991B (zh)	2007-11-22	2012-04-18	田边三菱制药株式会社	含有环状聚烯烃层的塑料容器
NZ590802A (en) *	2008-11-20	2013-05-31	Techno Guard Co Ltd	Formulation comprising a pyrazolone derivative and an amphiphilic solubilising agent
WO2010087306A1 (ja)	2009-01-29	2010-08-05	株式会社林原生物化学研究所	抗神経変性疾患剤
SMT201900337T1 (it)	2011-09-05	2019-07-11	Mitsubishi Tanabe Pharma Corp	Agente medicinale per trattare la sclerosi laterale amiotrofica o prevenire la progressione di una fase della sclerosi laterale amiotrofica
JP6298206B1 (ja)	2017-08-08	2018-03-20	田中　正彦	ピラゾロン誘導体を含む医薬
KR102665924B1 (ko)	2018-02-15	2024-05-14	후지모리 고교 가부시키가이샤	플라스틱 용기
WO2019167178A1 (ja)	2018-02-28	2019-09-06	田辺三菱製薬株式会社	３－メチル－１－フェニル－２－ピラゾリン－５－オン原薬の分析方法、筋萎縮性側索硬化症の治療および筋萎縮性側索硬化症の進行抑制、ならびに、３－メチル－１－フェニル－２－ピラゾリン－５－オン原薬を含む薬剤の製造方法
US11826352B2 (en)	2018-11-02	2023-11-28	Mitsubishi Tanabe Pharma Corporation	Edaravone suspension for oral administration
MX2021005144A (es)	2018-11-02	2021-07-15	Mitsubishi Tanabe Pharma Corp	Suspension de edaravona para administracion oral.
CA3198014A1 (en)	2020-11-12	2022-05-19	Hidetoshi Shimizu	Pharmaceutical composition for oral administration of edaravone and method of administering same
US12194025B2 (en)	2020-11-12	2025-01-14	Mitsubishi Tanabe Pharma Corporation	Pharmaceutical composition for oral administration of edaravone and method of administering same
WO2024005187A1 (ja) *	2022-07-01	2024-01-04	田辺三菱製薬株式会社	組成物、およびエダラボンの応答可能性の評価方法

1985
- 1985-05-20 JP JP10579885A patent/JPS61263917A/ja active Granted

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH01242526A (ja) *	1988-03-23	1989-09-27	Takeda Chem Ind Ltd	カルバメート化合物
US8076368B2 (en)	2003-11-12	2011-12-13	Lead Chemical Co., Ltd,	Percutaneous absorption type cerebral protective agent
JPWO2005054205A1 (ja) *	2003-12-05	2007-06-28	学校法人東海大学	蛋白修飾物生成抑制剤
JP4837992B2 (ja) *	2003-12-05	2011-12-14	学校法人東海大学	蛋白修飾物生成抑制剤

Also Published As

Publication number	Publication date
JPH0531523B2 (2)	1993-05-12

Similar Documents

Publication	Publication Date	Title
JPH0531523B2 (2)	1993-05-12
US4826860A (en)	1989-05-02	Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
US11529337B2 (en)	2022-12-20	Method of treating pain
PT99690B (pt)	1999-05-31	Metodo para o tratamento de doencas utilizando derivados de 2'-o-alquil-adenosina e para a preparacao de composicoes que os contem e de um hidrato de 6-ciclo- -hexil-2'-ometil-adenosina
LT3317B (en)	1995-06-26	Neuromuscular blocking agents
HU202106B (en)	1991-02-28	Process for producing pharmaceutical compositions containing pyrazolin derivatives
ES2210399T3 (es)	2004-07-01	Farmacos para profilaxis/tratamiento de las complicaciones de la diabetes.
JPH04264030A (ja)	1992-09-18	抗喘息剤
JPS6117574A (ja)	1986-01-25	カルシウム拮抗活性のある１‐〔ビス‐（４‐ルオロフエニル）‐メチル〕‐４‐（３‐フエニル‐２‐プロペニル）‐ヘキサヒドロ‐１ｈ‐１，４‐ジアゼピンとその製法及びそれを含有する医薬組成物
JPH03215426A (ja)	1991-09-20	血糖上昇抑制剤
US4918090A (en)	1990-04-17	Substituted 2-aminbenzothiazoles and derivatives useful as cerebrovascular agents
WO1994005290A1 (fr)	1994-03-17	Inhibiteur d'agregation plaquettaire
KR20020063254A (ko)	2002-08-01	신경계 장해의 치료 및/또는 예방약
JP2025534851A (ja)	2025-10-17	複素環化合物、ならびにその調製方法および使用
US6071968A (en)	2000-06-06	Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant
US4971983A (en)	1990-11-20	Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents
TW322473B (2)	1997-12-11
CN101648951A (zh)	2010-02-17	一种己酮可可碱衍生物
WO1994009784A1 (fr)	1994-05-11	Inhibiteur d'agregation plaquettaire
GB1559918A (en)	1980-01-30	3-phenoxypyridine derivative and its production
EP0223811A1 (en)	1987-06-03	Use of nicorandil or pinacidil for the treatment of peripheral vascular disease
JP2003267871A (ja)	2003-09-25	放射線障害予防剤
JPS63130592A (ja)	1988-06-02	過酸化脂質生成抑制剤
JPS59231057A (ja)	1984-12-25	カルボン酸アミド化合物およびその誘導体
US4024259A (en)	1977-05-17	3-Anilino-2,4-diazabicyclo[3.2.1]octenes

Legal Events

Date	Code	Title	Description
2006-03-07	S531	Written request for registration of change of domicile	Free format text: JAPANESE INTERMEDIATE CODE: R313531
2006-03-15	R350	Written notification of registration of transfer	Free format text: JAPANESE INTERMEDIATE CODE: R350
2007-04-24	S531	Written request for registration of change of domicile	Free format text: JAPANESE INTERMEDIATE CODE: R313531
2007-05-07	R350	Written notification of registration of transfer	Free format text: JAPANESE INTERMEDIATE CODE: R350
2009-10-30	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20110512 Year of fee payment: 18
2009-11-02	S531	Written request for registration of change of domicile	Free format text: JAPANESE INTERMEDIATE CODE: R313531
2009-11-13	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20110512 Year of fee payment: 18
2009-11-13	R371	Transfer withdrawn	Free format text: JAPANESE INTERMEDIATE CODE: R371
2010-05-20	EXPY	Cancellation because of completion of term
2010-08-04	FPAY	Renewal fee payment (event date is renewal date of database)	Free format text: PAYMENT UNTIL: 20110512 Year of fee payment: 18